Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Reexamination Certificate
2002-11-29
2008-10-07
Minnifield, N. M. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
C424S184100, C424S265100, C424S690000, C424S266100, C424S272100, C424S689000, C424S698000, C514S002600, C514S012200, C530S300000, C530S305000, C530S350000
Reexamination Certificate
active
07431936
ABSTRACT:
The present invention provides the RSP-1 and RSP-2 proteins which are involved in the cytoadhesion ofP. falciparumduring ring-stage infection of erythrocytes, antibodies which bind to the proteins, methods of screening for aP. falciparuminfection, methods of determining the infective stage ofP. falciparumand vaccines for protecting individuals fromPlasmodiumsp. infections.
REFERENCES:
patent: 4767622 (1988-08-01), Ristic et al.
patent: 5192807 (1993-03-01), Gysin et al.
patent: 5356927 (1994-10-01), Taraschi et al.
patent: 5573943 (1996-11-01), Saul et al.
patent: 5631278 (1997-05-01), Taraschi et al.
patent: 6828416 (2004-12-01), Lal et al.
patent: 6855323 (2005-02-01), Scherf et al.
patent: 2002/0055183 (2002-05-01), Gysin et al.
patent: 2004/0013671 (2004-01-01), Gysin et al.
patent: 2004/0018569 (2004-01-01), Gysin et al.
patent: 2005/0054828 (2005-03-01), Gysin et al.
patent: WO 93/04696 (1993-03-01), None
patent: WO 96/30026 (1996-10-01), None
patent: WO 01/92321 (2001-12-01), None
patent: WO 2004/069874 (2004-08-01), None
Douki et al, Blood, Jun. 2003, 101/12:5025-5032.
Genton et al, Trends in Parasitology, Jun. 2003, 19/6:264-270.
Sherman et al, Microbes and Infection, 2003, 5:897-909.
Hawthrone et al, Molecular and Biochemical Parasitology, 2004, 136:181-189.
Spielmann et al, Molecular and Biochemical Parasitology, 2000, 111:453-458.
Ramasamy, BBA, 1998, 1406:10-97.
Duffy et al, Trends in Parasitology, Aug. 2001, 17/8:354-356.
Shi et al, PNAS USA, Feb. 1999, 96:1615-1620.
Astagneau et al, Acta Tropica, 1994, 57:317-325.
Pawan et al, Vaccine, 1994, 12/9:819-824.
Gabriel et al, Molecular and Biochemical Parasitology, 1986, 20:67-75.
Scherf et al, Cellular Microbiology, 2001, 3/3:125-131.
Kurtis et al, Trends in Parasitology, May 2001, 17/5:219-223.
Joshi et al, Infection and Immunity, Jan. 2000, 68/1:141-150.
Kurtis et al, Infection and Immunity, Jul. 1999, 67/7:3424-3429.
Cox, Nature, Dec. 3, 1992, 360:417-418.
Taylor-Robinson et al, J. Protozool. Res., 2001, 11:1-18.
Collins et al, Nature, Sep. 1986, 323:259-262.
Schneider et al, Molecular and Biochemical Parasitology, 2004, 137:35-41.
Howard et al, Parasite Immunology, 1986, 8:57-68.
Douki et al, Blood, Jun. 15, 2003, 101/12:5025-5032.
Stowers et al, Infection and Immunity, Jun. 1997, 65/6:2329-2338.
Genton et al, Current Drug Targets—Immune, Endocrine & Metabolic Disorders, 2002, 2:255-267.
Locher et al, BBA-Protein Structure and Molecular Enzymology, Dec. 1992, 1160/3:275-280 abstract only.
Baldi et al, EMBO Journal, 2000, 19/11:2435-2443.
Anders et al, Biochem. Soc. Symp., 1987, 53:103-114.
Stowers et al, Vaccine96 Cold Spring Harbor Laboratory Press, 1996, pp. 249-253.
Hughes et al, Molecular and Biochemical Parasitology, 1995, 71:99-113.
Dubois et al, J. Immunological Methods, 1997, 208:29-34.
Coppel et al, Molecular and Biochemical Parasitology, Dec. 1988, 31/3:223-231 abstract only.
Howard et al, Molecular and Biochemical Parasitology, 1998, 92:111-122.
B. Pouvelle, et al., Nature Medicine, vol. 6, No. 11, XP-002199895, pp. 1264-1268, “Cytoadhesion of Plasmodium Falciparum Ring-Stage-Infected Erythrocytes”, Nov. 2000.
Y-F. Yang, et al., Molecular and Biochemical Parasitology, vol. 26, No. 1-2, XP-001073690, pp. 61-67, “The Primary Structure of a Plasmodium Falciparum Polypeptide Related to Heat Shock Proteins”, 1987.
B. L. Pasloske, et al., Gene, vol. 144, No. 1, XP-002199896, pp. 131-136, “PfEMP3 and HRP1: Co-Expressed Genes Localized to Chromosome 2 of Plasmodium Falciparum”, 1994.
S. Uni, et al., American Journal of Tropical Medicine and Hygiene, vol. 36, No. 3, XP-001073686, pp. 481-488, “Ultrastructural Localization of the 150/130 KD Antigens in Sexual and Asexual Blood Stages of Plasmodium Falciparum-Infected Human Erythrocytes”, 1987.
U.S. Appl. No. 11/376,124, filed Mar. 16, 2006, Gysin, et al.
Quakyi et al, Infection and Immunity (1989) 57(3), 833-839.
Silva et al, Molecular Microbiology (2005) 56(4), 990-1003.
Culvenor et al, Infection and Immunity (1991) 59(3), 1183-1187.
Jana S. McBride, et al.: “Polymorphism of a High Molecular Weight Schizont Antigen of the Human Malaria Parasite Plasmodium Falciparum”: J. Exp. Med., vol. 161, Jan. 1985, pp. 160-180.
Chairat Uthaipibull, et al.: “Inhibitory and Blocking Monoclonal Antibody Epitopes on Merozoite Surface Protein 1 of the Malaria Parasite Plasmodium falciparum”: J. Mol. Biol., 2001, pp. 1381-1394.
Ana Szarfman, et al.: “Allelic Forms of gp195, a Major Blood-Stage Antigen ofPlasmodium Falciparum, are Expressed in Liver Stages”: Journal of Experimental Medicine, vol. 167, Jan. 1988, pp. 231-236.
Buffet Pierre
Gysin Juerg
Pouvelle Bruno
Scherf Artur
Centre National de la Recherche Scientifique
Institut Pasteur
Minnifield N. M.
Oblon & Spivak, McClelland, Maier & Neustadt P.C.
LandOfFree
Proteins involved in cytoadhesion of plasmodium falciparum... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Proteins involved in cytoadhesion of plasmodium falciparum..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Proteins involved in cytoadhesion of plasmodium falciparum... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4014410